Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study

[1]  M. de Montalembert,et al.  Sickle cell disease: a comprehensive program of care from birth. , 2019, Hematology. American Society of Hematology. Education Program.

[2]  F. Piel,et al.  HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges , 2019, Blood cells, molecules & diseases.

[3]  K. Maitland,et al.  The epidemiology of sickle cell disease in children recruited in infancy in Kilifi, Kenya: a prospective cohort study , 2019, The Lancet. Global health.

[4]  Gregory S Kabadi,et al.  Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania. , 2019, International health.

[5]  G. Tomlinson,et al.  Hydroxyurea for Children with Sickle Cell Anemia in Sub‐Saharan Africa , 2019, The New England journal of medicine.

[6]  Marie-Dominique Hardy-Dessources,et al.  Point‐of‐care screening for sickle cell disease in low‐resource settings: A multi‐center evaluation of HemoTypeSC, a novel rapid test , 2018, American journal of hematology.

[7]  R. Ware,et al.  Building a sickle cell disease screening program in the Republic of Uganda: the Uganda Sickle Surveillance Study (US3) with 3 years of follow-up screening results. , 2018, Blood advances.

[8]  G. Guernec,et al.  Diagnostic accuracy in field conditions of the sickle SCAN® rapid test for sickle cell disease among children and adults in two West African settings: the DREPATEST study , 2018, BMC Hematology.

[9]  R. Cooper,et al.  White Paper: Pathways to Progress in Newborn Screening for Sickle Cell Disease in Sub-Saharan Africa , 2018, Journal of tropical diseases & public health.

[10]  K. Neville,et al.  Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial) , 2016, American journal of hematology.

[11]  R. Ware,et al.  Sickle cell disease , 2017, The Lancet.

[12]  A. Habib,et al.  Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis , 2016, BMC Health Services Research.

[13]  R. Ware,et al.  Burden of sickle cell trait and disease in the Uganda Sickle Surveillance Study (US3): a cross-sectional study. , 2016, The Lancet. Global health.

[14]  Xiaoxi Yang,et al.  Validation of a novel point of care testing device for sickle cell disease , 2015, BMC Medicine.

[15]  Patrick T. McGann.  Improving survival for children with sickle cell disease: newborn screening is only the first step , 2015, Paediatrics and international child health.

[16]  J. Eckman,et al.  Newborn screening for sickle cell diseases in the United States: A review of data spanning 2 decades. , 2015, Seminars in perinatology.

[17]  I. Hambleton,et al.  The Chhattisgarh state screening programme for the sickle cell gene: a cost-effective approach to a public health problem , 2015, Journal of Community Genetics.

[18]  B. Therrell,et al.  Barriers to implementing sustainable national newborn screening in developing health systems , 2014 .

[19]  J. Knight-Madden,et al.  Newborn screening for sickle cell disease in Jamaica: a review - past, present and future. , 2014, The West Indian medical journal.

[20]  Anand P. Patil,et al.  Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates , 2013, The Lancet.

[21]  Thomas N. Williams,et al.  Sickle Cell Disease in Africa , 2011, American journal of preventive medicine.

[22]  F. Kirkham,et al.  Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania , 2011, PloS one.

[23]  F. Vertongen,et al.  Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns , 2008, Journal of Clinical Pathology.

[24]  M. Odunvbun,et al.  Newborn screening for sickle cell disease in a Nigerian hospital. , 2008, Public health.

[25]  K. Ohene-Frempong,et al.  SCREENING NEWBORNS FOR SICKLE CELL DISEASE IN GHANA , 2008, Pediatrics.

[26]  Alla Joutovsky,et al.  HPLC retention time as a diagnostic tool for hemoglobin variants and hemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. , 2004, Clinical chemistry.

[27]  Nigeria.,et al.  Nigeria Demographic and Health Survey 2008 , 2004 .

[28]  M. C. Rahimy,et al.  Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting. , 2003, Blood.

[29]  S. Bewley,et al.  The comprehensive care of sickle cell disease , 2002 .

[30]  M A Waclawiw,et al.  Stroke prevention trial in sickle cell anemia. , 1998, Controlled clinical trials.

[31]  Graham R Serjeant,et al.  Sickle-cell disease , 1984, The Lancet.

[32]  E Vichinsky,et al.  Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. , 1986, The New England journal of medicine.

[33]  G. Maude,et al.  Prevention of pneumococcal infection in children with homozygous sickle cell disease. , 1984, British medical journal.